| Literature DB >> 20692608 |
Abstract
RAS proteins conduct signaling from surface receptors to cytoplasmic effectors, and RAS gain-of-function mutations are pervasive in cancer. A new mechanism for RAS signal attenuation with implications for receptor trafficking has been uncovered. Copyright (c) 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20692608 PMCID: PMC2950067 DOI: 10.1016/j.cub.2010.06.019
Source DB: PubMed Journal: Curr Biol ISSN: 0960-9822 Impact factor: 10.834